FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a compound of formula
, or to a pharmaceutically acceptable salt of the compound Ia where X represents CH; Z represents N; Y represents C with -NH2 attached to Y; p is equal to 1, B represents a halogen atom; A represents the group 
, and D represents an unbranched lower alkyl. Also, the invention refers to a pharmaceutical composition based on the compound of formula la and to the application of the compound of formula la in preparing a drug.
EFFECT: there are prepared new quinoline derivatives effective in treating the retinal diseases of aetiology including A2E and/or lipofuscin accumulation in retinal tissues in a subject.
9 cl, 10 dwg, 2 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| AMIDE DERIVATIVES OF N-CARBAMIDE-SUBSTITUTED AMINO ACIDS AS MODULATORS OF FORMYLPEPTIDE RECEPTOR-1 (FPRL-1) | 2012 |
|
RU2744577C2 |
| METHOD AND COMPOSITION FOR TREATING MACULAR DEGENERATION | 2010 |
|
RU2548762C2 |
| DERIVATIVES OF N-UREA-SUBSTITUTED AMINOACIDS AS MODULATORS OF FORMYL-PEPTIDE RECEPTOR | 2014 |
|
RU2696581C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| HETEROCYCLIC COMPOUND, METHOD FOR ITS PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2221792C2 |
| DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
| COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | 2012 |
|
RU2606128C2 |
| AMID DERIVATIVES OF N-CARBAMIDE-SUBSTITUTED AMINO ACIDS AS MODULATORS OF FORMYLPEPTIDE RECEPTOR-1 (FPRL-1) | 2012 |
|
RU2629205C2 |
